Jian-xiong Chen, MD, FAHA
Professor
Department:
SOM-Pharmacology/Toxicology
Email:
jchen3@umc.edu
Work Phone:
(601) 984-1731
Biography
I am a tenure professor in the department of Pharmacology and Toxicology. I received the M.D. and a master’s degree in pharmacology from Central South University of China. I completed the join PhD program at Southern Illinois University school of Medicine and Central south university. I then continued postdoctoral training in pathology at Vanderbilt University Medical Center. I served as an assistant professor in Pathology, and became associate professor of Pediatrics at Vanderbilt University from 2002-2010. I joined the University of Mississippi Medical Center as an associate professor at Department of Pharmacology and Toxicology in 2011. I am Fellow of American Heart Association (AHA) and member of American Physiology Society. I have served as a grant reviewer committee of NIH, AHA and British Medical Research Council. I have been a part of a very successful research team that have been well-funded by NIH and AHA. My current research interesting is focus to understanding the intracellular molecular mechanisms that regulate coronary microvascular dysfunction, heart failure with preserved ejection fraction (HFpEF) and diabetic cardiomyopathy, then, to develop novel gene therapies for the treatment devastating heart failure. I am the author of 83 peer-reviewed publications and currently funded by National Heart, Lung and Blood Institute. I serves as Editor of Journal of cardiovascular pharmcology.
Education
| Vanderbilt University Medical Center, Postdoctoral Fellow, pathology | 2001 |
| Henan Medical University, MS, pharmacology | 1990 |
| Hunan Medical University, MD, Medicine | 1985 |
Current Positions
| Professor, School of Medicine | 07/2018 - Present |
| The University of Mississippi Medical Center Jackson, Mississippi 39216 | |
Academic Appointments or Other Previous Appointments
| Associate Professor, University of Mississippi Medical Center, School of Medicine, Department of Pharmacology / Toxicology | 2011 - 07/2018 |
| Associate Professor, vanderbilt, School of Medicine, Department of Pediatrics | 2010 - 2011 |
| Assistant Professor, vanderbilt, School of Medicine, Department of Pathology | 2002 - 2010 |
| Department Chair, Hengyang Medical College, School of Medicine | 1992 - 03/1996 |
| Associate Professor, Hengyang Medical College, School of Medicine | 1992 - 03/1996 |
| Assistant Professor, Hengyang Medical college, School of Medicine | 07/1985 - 07/1987 |
Sponsored Program Funding
| Extramural, P53 acetylation in microvascular rarefaction and heart failure, NHLBI | 12/2024 - 11/2028 |
| Extramural, Inactivation of Sirt3-mediated ferroptosis in the heart of Friedreich’s ataxia, NHLBI | 12/2024 - 11/2028 |
| Extramural, Notch3 in coronary microvascular dysfunction and diastolic dysfunction of diabetes, NHLBI | 12/2024 - 11/2028 |
| Extramural, p53 acetylation in microvascular rarefaction and heart failure, NHLBI | 09/2022 - 08/2023 |
| Extramural, Endothelial PHD2 in hypertensive vascular remodeling, NHLBI/NIGMS | 09/2021 - 06/2025 |
| Extramural, Altered Coronary Endothelial-Pericyte Interactions in Diabetes, NHLBI | 10/2020 - 09/2024 |
| Intramural, Altered Coronary Endothelial-Pericyte Interactions in Diabetes, UMMC | 10/2019 - 09/2020 |
| Extramural, Coronary microvascular rarefaction in diabetic/obese heart, NHLBI | 03/2017 - 02/2021 |
| Intramural, coronary microvascular rarefaction in diabetic/obese heart, UMMC | 10/2016 - 09/2017 |
| Extramural, Regulation of vascular maturation/regression in diabetes, NIH/NHLBI | 07/2010 - 03/2016 |
| Extramural, Functional Role of Angiopoietin-2 in Diabetic Heart, NIH/NIDDK | 04/2006 - 03/2010 |
| Extramural, Angiopoietins/Tie-2 and Diabetic Impaired Myocardial Angiogenesis, American Heart Association | 07/2005 - 06/2007 |
| Extramural, Hsp90/Client Protein Interactions in the Newborn Lung, NIH/NHLBI | 04/2005 - 03/2009 |
| Extramural, Effects of Hypoxia on the Coronary Microcirculation, NIH/NHLBI | 06/2000 - 05/2005 |
Publications
Journal Article | |
| Chen JX, Wu HX, Wang Y The role of endotoxin in the bronchial hyperreactivity formation Chinese Medical Journal. 1994; 74(1):38-9, 64 | |
| Chen JX, Cao YS Protection ammonium glycyrrhizanate against endotoxin-induced bronchial hyperreactivity. Chinese Journal of Pharmacology and Toxicology, 1994, 8(3):235-236. | |
| Chen JX, Cao YS. Effect ammonium glycyrrhizanate against endotoxin-induced bronchial hyperreactivity-in relation to beta-cAMP system. Chinese Traditional and Herbal Drugs, 1994, 1(1):17-18. | |
| Chen JX, Tang XQ, Zhu BY, Liao DF. The mechanism of exogenous oxygen free radicals induced vasospasm of isolated basilar artery. Chinese Journal Arteriosclerosis, 1994, 2(2):88-91. | |
| Chen JX, Liao DF, Yu L, Xiao GL, Zhu BY, Tang XQ. Protective effect of captopril on electrolyzed perfusion solution induced vasospasm of isolated basilar artery. Chinese Journal of Pharmacology and Toxicology, 1995, 9(1):44-46. | |
| Chen JX, Liao DF, Tang XQ, Yu L, Zeng H, Cao JG. Protection of Gypenosides against oxygen free radical induced vasospasm of isolated rabbit basilar artery. Chinese Traditional and Herbal Drugs, 1997, 28(4):219-221. | |
| Liao DF, Chen JX, Huang HL, Tang XQ, Cao JG and Yu L. Correlation between the protection of probucol on injury of endothelial cells by free radicals and the activity of nitric oxide Chinese Journal Arteriosclerosis, 1994, 2(2):67-71. | |
| Wan Y, Weng SA, Chen JX, Wu HX, Cao YS. Effects of estradiol on asthma of guinea pigs and its relationship to beta-adrenergic receptors. Chinese Pharmacological Bulletin, 1993, 9(4):295-297. | |
| Xiao GL, Liao DF, Chen JX, Yu L. Protective effect of gypenosides on OFR-induced damage of relaxing capacity of rabbit thoracic aortae in vitro. Chinese Pharmacological Bulletin, 1994, 10(2):136-138. | |
| Li LX, Yu L, Chen JX, Liao DF, Cao JG, Chen LX, Huang HL and Zhu BY. Oxidized low density lipoprotein promotion of adhesion of monocytes to endothelial cells in vitro. Chinese Journal Arteriosclerosis, 1996, 4(4):272-275. | |
Book Chapter | |
| Chen JX, Zeng H, Chen X, Su CY, Lai CC. Heme oxygenase, Ginkgo biloba extract and its terpenoids protect myocytes against oxidative injury. In: Heme Oxygenase in Biology and Medicine. NG Abraham, ed., 2002, pp. 399-408. | |
Presentations
| Poster Presentation, Deficiency Of Sirtuin 3 In Endothelium Reduces Endothelial-Dependent Relaxation And Impairs Myogenic Response In Coronary And Middle Cerebral Arteries Of Mice, AHA | 11/2023 |
| Poster Presentation, Endothelial Phd2 Deficiency Promotes Angiotensin-Ii-Induced Arterial Stiffness And Coronary Microvascular Dysfunction, North American Vascular Biology | 10/2023 |
| Poster Presentation, Treatment with PFKFB3 inhibitor potentially improves diastolic function and arterial stiffness in PHD2ECKO mice, APS summit | 04/2023 |
| Poster Presentation, Potential role of Ferrostatin-1 as a mitochondrial-targeting agent for the treatment of mitochondrial cardiomyopathy, APS summit | 04/2023 |
| Poster Presentation, Ferrostatin-1 Ameliorates Cardiac Dysfunction in a Cardiomyocyte-Specific SIRTUIN 3 Knockout Mouse Model (Excellent Post Award), Hypertension, AHA | 09/2022 |
| Poster Presentation, Regulatory Role Of Endothelial Phd2 On Hypertensive Arterial Stiffness And Vascular Calcification, Vascular Discovery, AHA | 05/2022 |
| Poster Presentation, Novel Regulatory Role of SIRT3 on Cardiomyocyte Mitochondrial Frataxin and Ferroptosis, EB meeting | 05/2022 |
| Platform Presentations, Deficiency of Sirtuin 3 disrupts endothelial glucose metabolism and sensitizes pressure-overload induced heart failure | 11/2019 |
| Poster Presentation, Deficiency of sirtuin 3 accentuates angiotensin II-induced arterail stiffness/myocardial fibrosis and hypertension, EB Meeting | 04/2019 |
| Poster Presentation, regulatory role of endothelial sirt3 on blood pressure and diastolic dysfunction in a female mice., Hypertension, AHAH | 09/2018 |
| Poster Presentation, ablation of endothelial sirt3 exacerbates pressure overload-induced heart failure, BCVS, AHA | 08/2018 |
| Poster Presentation, Sirtuin 3 attenuates diabetic cardiomyopathy via suppression of p53 acetylation and regulating cardiomyocyte metabolism, Experimental Biology, San Diego | 04/2018 |
| Poster Presentation, Deletion of endothelial Sirt3 causes diastolic dysfunction, AHA council on hypertension, San Francisco, CA | 09/2017 |
| Poster Presentation, Treatment with Prolyl Hydroxylase Inhibitor Reverses Pre-Existing Diastolic Dysfunction in the Aged SIRT3 Knockout Mice, 2017 Experimental Biology in Chicago, Chicago, IL | 04/2017 |
| State/Local Invited Seminars/Lectures, New perspective of Angiopoietins/Tie-2 system in Sepsis, Fushan Hospital, Guang Dong, P.R. China | 05/2016 |
| State/Local Invited Seminars/Lectures, Emerging role of Sirtuin 3 in EC metabolism and diastolic dysfunction, Human University of Chinese Medicine, P.R. China | 05/2016 |
| Poster Presentation, Deletion of Endothelial Sirt3 Causes Coronary Microvascular Dysfunction and HFpEF., Experimental Biology, San Diego, CA | 04/2016 |
| Regional Invited Seminars/Lectures, Emerging role of Sirtuin 3 in EC metabolism and angiogenesis”., University of Southern Illinois, School of Medicine, Department of Microbiology and Biochemistry, Springfield, IL | 09/2015 |
| National and International Invited Seminars/Lectures, New perspective of Angiopoietins/Tie-2 system in Sepsis, Human University of Chinese Medicine, P.R. China., Changsha | 05/2015 |
| National and International Invited Seminars/Lectures, Mechanisms of impairment of myocardial angiogenesis in type II diabetes, University of Beijing Medical Center, Department of Physiology and Physiopathology., Beijing | 09/2014 |
| National and International Invited Seminars/Lectures, New perspective of Angiopoietins/Tie-2 system in Sepsis, Summit of international critical care 2014, Beijing | 09/2014 |
| Platform Presentations, SIRT3 Deficiency Impairs Hypoxic Signaling, Reprograms Basal Glycolytic Metabolism and Exacerbates Myocardial Ischemic Injury., Experimental Biology, Boston, MA | 03/2014 |
| Platform Presentations, Sirt3 is essential for apelin-gene therapy mediated cardiac repair in post-myocardial infarction of diabetes., High blood pressure Research Scientific sessions, New orleans | 09/2013 |
| Poster Presentation, Sirt3 regulates oxygen sensors and blood vessel formation in the heart., High Blood Pressure Research (HBPR), New Orleans, LA | 09/2013 |
| State/Local Invited Seminars/Lectures, Mechanisms of impairment of myocardial angiogenesis in type II diabetes, University of Mississippi Medical Center, Department of Biochemical Science, Jackson, MS. | 12/2012 |
| Poster Presentation, Apelin-13 Increases Myocardial Progenitor Cells and Improves Myocardial Remodeling of Post-myocardial, Hypertension council meeting, New orlean | 09/2012 |
| Poster Presentation, Regulation Of Sirt3 And Autophagy By Bone Marrow Cells Therapy Improves Cardiac Repair In Post-myocardial Infarction Mice., AHA meeting, Dallas | 07/2012 |
| Poster Presentation, Apelin Reduces Myocardial Infarction Size and Promotes Angiogenesis by Increasing SDF-1/CXCR4 and AKT/eNOS/VEGF pathways, AHA meeting, Dallas | 07/2012 |
| Poster Presentation, Ang-1 reduces myocardial infarction via upregulation of SDF-1/CXCR4 and recruiting hematopoietic progenitor cells in the diabetic db/db mouse model., AHA, Orlando, FL | 11/2011 |
| Regional Invited Seminars/Lectures, Angiopoietins/Tie-2 system in diabetic complications, University of Southern Mississippi, Department of Biological Science, Hattiesburg, MS | 11/2011 |
| Poster Presentation, Overexpression of angiopoietin-2 promotes myocardial fibrosis and rarefaction in diabetic db/db mouse model., EB meeting, Washington, DC | 04/2011 |
| State/Local Invited Seminars/Lectures, Angiopoietins/Tie-2 in diabetic infarcted heart, University of Mississippi Health Center, Department of Physiology& Biophysics, Jackson, MS. | 03/2011 |
| Regional Invited Seminars/Lectures, Angiopoietins/Tie-2 system in diabetic vascular complications, Department of Pharmacology, University of Mississippi medical Center, Jackson, MS | 07/2010 |
| Regional Invited Seminars/Lectures, Angiopoietins/Tie-2 system and diabetic abnormal angiogenesis, Department of Pharmacology and Physiology, University of Missouri, Columbia, MO | 05/2010 |
| State/Local Invited Seminars/Lectures, NADPH oxidase and diabetic angiogenesis, Beijing University Medical Center, Beijing, PR China | 07/2008 |
| Regional Invited Seminars/Lectures, Angiopoietins/Tie-2 in diabetic complications, University of South China, Hengyang, Hunan, PR. China. | 07/2008 |
| Poster Presentation, Inhibition of protein tyrosine phosphatase improves hyperglycemic impaired angiogenesis., CIRCULATION, 16: 25-25; 2007 (Poster) | 11/2007 |
| Platform Presentations, Leptin stimulates angiogenesis in myocardial endothelial cells: Involvement of p47phox NADPH oxidase., Experimental Biology meeting, FASEB JOURNAL 21: A180-A180; 2007. | 04/2007 |
| Platform Presentations, High glucose blunts angiopoietin-1 (Ang-1)-induced angiogenesis in myocardial endothelial cells via impairment of Akt and eNOS phosphorylation., FASEB JOURNAL 21: A130-A131; 2007. | 04/2007 |
| Platform Presentations, Hypoxia/reoxygenation-induced myocardial angiogenesis: Role of NADPH oxidase derived reactive oxygen species (ROS), AHA meeting, CIRCULATION 114: 155-155; 2006. | 11/2006 |
| State/Local Invited Seminars/Lectures, Angiogenesis and cardiovascular diseases, University of South China, Hengyang, Hunan, PR. China. | 06/2006 |
| Platform Presentations, Role of NADPH oxidase-derived reactive oxygen species (ROS) in angiopoietin-1-induced angiogenesis, Experimental biology meeting, FASEB JOURNAL 18: A385-A385; 2004. | 03/2004 |
| Platform Presentations, Hypoxia increases heat shock protein 90 binding (Hsp90) to endothelial nitric oxide synthase (eNOS) via a P13-Akt pathway in porcine coronary artery endothelium (PCAEC) ., Experimental Biology Meeting; San Diego, FASEB JOURNAL 17: A805-A805; 2003 | 04/2003 |
Honors, Awards, and Recognition
| Excellence in Research Award,Golden Level., The University of Mississippi Medical Center | 2013 |
| Excellence in Research Award, Silver Level., The University of Mississippi Medical Center | 2012 |
| Excellence in Research Award,Bronze Level., The University of Mississippi Medical Center | 2011 |
| Achievement Award in Science and Technology, Ministry of Science and Technology of Hunan Province, P. R. China | 1999 |
| Achievement Award in Cardiovascular Research, Bureau of Medicine and Hygiene of Hunan Province, P. R. China | 1999 |
| Recipient of Excellent Award in Teaching, Education Commissioner of P.R. China | 1994 |
| Recipient of Excellent Award in Teaching, Education Commissioner of Hunan province, P.R. China | 1992 |
Professional Membership and Service
| North American Vascular Biology Organization, Member | 2023 - Present |
| American Heart Association, Member | 2001 - Present |
| American Physiological Society, Member | 2001 - Present |
Committee Service
| P&T committee, Member | 2018 - Present |
| Research day, Member | 2016 - 2016 |
| Strategic planning/COBRE/PPG committee, Member | 2016 - Present |
| Professional Education committee, Member | 2013 - Present |
| Graduate Program Committee, Member | 2012 - Present |
| Department Faculty recruitment committee, Member | 2012 - Present |
Other Service
| Editor | 05/2024 - Present |
| Pilot grant | 09/2023 - 09/2023 |
| Nature Reviews Cardiology | 06/2023 - 06/2023 |
| CARDIOVASCULAR DIFFERENTIATION AND DEVELOPMENT STUDY SECTION, NIH | 02/2023 - 02/2023 |
| Ad Hoc reviewer for Special Emphasis Panel/Scientific Review Group ZRG1 F10C-C | 05/2022 - 05/2022 |
| Ad hoc reviewer for NIH Special Emphasis Panel (SEP), ZRG1 CVRS B_02. | 07/2021 - 07/2021 |
| Ad hoc reviewer for NIH Special Emphasis Panel/Scientific Review | 07/2020 - 07/2020 |
| cardiac group grant review | 07/2020 - Present |
| Pilor grant | 09/2019 - 09/2019 |
| Chair of EB meeting section: Diabetes: A metabolic Karma | 04/2019 - 04/2019 |
| Ad hoc reviewer for NIH Special Emphasis Panel/Scientific Review | 06/2018 - 06/2018 |
| Ad hoc reviewer for NIH Special Emphasis Panel/Scientific Review | 10/2017 - 10/2017 |
| Ad hoc reviewer for NIH Special Emphasis Panel/PPG Review, member | 06/2015 - 06/2015 |
| Ad hoc reviewer for NIH Special Emphasis Panel/Scientific Review, member | 05/2015 - 05/2015 |
| Journal of cardiovascular pharmacology | 2015 - Present |
| Ad hoc reviewer for NIH Special Emphasis Panel/Scientific Review, member | 02/2014 - 02/2014 |
| Journal of Contemporary Diabetes Research | 2014 - Present |
| Diabetes Research-open Journal | 2014 - 12/2017 |
| Ad hoc reviewer for NIH Special Emphasis Panel/Scientific Review, member | 10/2013 - 11/2013 |
| Ad hoc reviewer for NIH Special Emphasis Panel/Scientific Review, member | 05/2013 - 05/2013 |
| Ad hoc reviewer for NIH Special Emphasis Panel/Scientific Review, member | 01/2013 - 01/2013 |
| Cardiovascular Genetics and Systems Medicine | 2013 - Present |
| Ad hoc reviewer for NIH-Cell, Molecular, and Computational Biology, member | 11/2012 - 11/2012 |
| Ad hoc reviewer for Medical Research Council (United Kingdom), member | 05/2012 - 05/2012 |
| Regular Reviewer for Vascular Wall Biology Committee of American Heart Association (Vas Wall Bio AAGI BSc2), member | 05/2011 - 10/2013 |
| Reviewer: Journal of cardiovascular pharmacology, JAHA, Cell Physiol Biochem, oncotarget, Acta Pharmacological Sin; Acta Biochim Biophys Sin; American Journal of Pathology; European Journal of Pharmacology; Journal of Thrombosis and Heamostasis; Canadian Journal of Physiology and Pharmacology, Clinical and Experimental Pharmacology and Physiology; Journal of Pediatric Endocrinology and Metabolism; Arterioscler Thromb Vasc Biol; PLoS ONE; Diabetes; Biochemical and Biophysical Research Communications, experimental cell research | 2011 - Present |
Teaching Experience
| Dentistry, Lecture, Lecturer, Dental Pharmacology | Annual 2018-2024 - 2024 |
| 1, Medicine, Lecture, Lecturer, Medical Pharmacology | Annual 2018-2024 |
| 1, Graduate, Lecture, Lecturer, the mechanisms of drug action | Annual 2018-2024 |
| 1, Graduate, Lecture, Lecturer, Pharmacology mechanisms | Annual 2018-2024 |
| 1, Dentistry, Small Group, Course Presenter, Review Session | Annual 2018-2024 |
| 1, Medicine, Small Group, Course Presenter, Medical pharmacology Review Session | Annual 2018-2024 |
| 1, Dentistry, Course, Course Director, dental pharmacology | Annual 2017-2024 |
| Dentistry, Lecture, Lecturer, anti-histamine drugs | Spring 2017 |
| Dentistry, Lecture, Lecturer, Asthma therapeutic | Spring 2017 |
| Dentistry, Course, Course Director, Dental pharmacology | Spring 2017 |
| Graduate, Lecture, Lecturer, Approaches to study Control of Angiogenesis | Spring 2017 |
| 4, Medicine, Small Group, Facilitator, autonomic drug responses | Fall 2017 - 2017 |
| 1, Medicine, Lecture, Lecturer, Histamine and H1 receptor antagonists | Fall 2017 - 2017 |
| 1, Medicine, Lecture, Lecturer, Drug used in the treatment of asthma | Fall 2017 - 2017 |
| 4, Medicine, Small Group, Facilitator, cardiovascular case study | Fall 2017 |
| 2, Graduate, Lecture, Lecturer, angiogenesis & vessel rarefication II | Fall 2017 - 2017 |
| Dentistry, Lecture, Lecturer, Asthma therapeutic | Spring 2016 |
| Dentistry, Lecture, Lecturer, Anti-histamine drugs | Spring 2016 |
| Medicine, Small Group, Facilitator, AAP section | Spring 2016 |
| 2, Medicine, Small Group, Facilitator, Medical pharmacology group studies | Fall 2016 |
| Medicine, Lecture, Lecturer, Asthma therapeutic | Fall 2016 |
| Medicine, Lecture, Lecturer, Anti-histamine drugs | Fall 2016 |
| Dentistry, Lecture, Lecturer, Asthma therapeutic | Spring 2015 |
| Dentistry, Lecture, Lecturer, Anti-histamine drugs | Spring 2015 |
| Medicine, Lecture, Lecturer, Anti-histamine drugs | Fall 2015 |
| Medicine, Lecture, Lecturer, Asthma therapeutic | Fall 2015 |
| Medicine, Small Group, Facilitator, AAP section | Fall 2015 |
| Medicine, Small Group, Facilitator, AAP section | Spring 2015 |
| Dentistry, Lecture, Lecturer, Asthma therapeutic | Spring 2014 |
| Medicine, Lecture, Lecturer, Asthma therapeutic | Fall 2014 |
| Dentistry, Lecture, Lecturer, Anti-histamine drugs | Spring 2014 |
| Medicine, Lecture, Lecturer, Anti-histamine drugs | Fall 2014 |
| 8 hours, Medicine, Small Group, Facilitator, Medical pharmacology group studies | Fall 2014 |
| 4, Medicine, Small Group, Facilitator, cardiovascular case study | Fall 2014 |
| 4 hours, Graduate, Lecture, Lecturer, the mechanisms of drug action-cardiovascular disease and angiogenesis | Fall 2013 |
| 8 hours, Medicine, Small Group, Facilitator, Medical pharmacology group studies | Fall 2013 |
| 4, Medicine, Small Group, Facilitator, cardiovascular case study | Fall 2013 |
| 4 hours, Graduate, Lecture, Lecturer, the mechanisms of drug action | Fall 2012 |
| Medicine, Small Group, Facilitator, Medical pharmacology group studies | Fall 2012 |
| 4, Medicine, Small Group, Facilitator, cardiovascular case study | Fall 2012 |
| Graduate, Lecture, Lecturer, the mechanisms of drug action-angiogenesis | Fall 2011 |
| Medicine, Small Group, Facilitator, Medical pharmacology group studies | Fall 2011 |
| 4, Medicine, Small Group, Facilitator, cardiovascular case study | Fall 2011 |
Directed Student Learning
| Dissertation Committee Member, Advised: umesh Bhattarai | 2020 - Present |
| Dissertation Committee Member, Effects of beta-amyloid on cerebral hypoperfusion in Alzheimer's diseases Advised: Xing Fang | 2019 - 2023 |
| Dissertation Committee Member, The impact of insulin resistance and inflammation during renal injury associated with prepubertal obesity Advised: Ubong Ekperikpe | 2019 - 2023 |
| Dissertation Committee Chair, Endothelial PHD2 in heart failure Advised: Quinesha Williams | 2019 - 2023 |
| Dissertation Committee Chair, Targeting ferroptosis in mitochondrial cardiomyopathy Advised: Aubrey C Cantrell | 2019 - Present |
| Supervised Research, Advised: Sumit Sontakke | 2017 - 2017 |
| Supervised Research, The role of mitochondrial oxidative stress in the pathophysiology of Preeclampsia Advised: Venkata Ramana Vaka | 2014 - 2015 |
| Doctoral Advisory Committee Chair, The Role of Endothelial SIRT3 in Cardiac Hypertrophy and Heart Failure Advised: Xiaochen He | 2012 - 2017 |
| Doctoral Advisory Committee Member, Importance of STAT3 in Hypertension-Induced Remodeling of the Heart Advised: Fouad Zouein | 2012 - 2014 |
| Doctoral Advisory Committee Member, Regulation of Inflammatory JAK-STAT Signaling: Implications for Cardiac Repair and Remodeling Advised: Carlos Zgheib | 2011 - 2013 |
Fellows supervised
| Postdoctoral fellow, Training Faculty, 8 fellows supervised | 05/2011 - 10/2016 |